Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I, Open Label Study in Healthy Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of Varying Oral Dosing Regimens for F901318

Next Previous
Trial Profile

A Phase I, Open Label Study in Healthy Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of Varying Oral Dosing Regimens for F901318

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Aug 2018

At a glance

  • Drugs Olorofim (Primary) ; Midazolam
  • Indications Aspergillosis
  • Focus Adverse reactions
  • Sponsors F2G

    • Most Recent Events

    • 31 Jul 2018 Status changed from recruiting to completed.
    • 13 Feb 2018 Planned End Date changed from 1 Mar 2018 to 1 Apr 2018.
    • 13 Feb 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top